The Effect of Pluchea indica (L.) Less. Tea on Blood Glucose and Lipid Profile in People with Prediabetes: A Randomized Clinical Trial

被引:7
|
作者
Sirichaiwetchakoon, Kittipot [1 ]
Churproong, Seekaow [2 ]
Kupittayanant, Sajeera [1 ]
Eumkeb, Griangsak [1 ]
机构
[1] Suranaree Univ Technol, Inst Sci, Dept Preclin Sci, 111 Univ Ave, Muang 30000, Nakhonratchasim, Thailand
[2] Suranaree Univ Technol, Inst Med, Dept Family Med & Community Med, Muang, Nakhonratchasim, Thailand
关键词
P; indica (L; ) Less; tea; Camellia sinensis tea; antihyperglycemia; antidyslipidemia; toxicity; clinical trial; GREEN TEA; BETA-CARYOPHYLLENE; ALPHA-GLUCOSIDASE; NATURAL SESQUITERPENE; FATTY LIVER; METABOLISM; EXTRACT; RISK; DYSLIPIDEMIA; HYPOGLYCEMIA;
D O I
10.1089/acm.2020.0246
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objective: Diabetes mellitus and dyslipidemia are currently increasing dramatically, and conventional medicine in the treatment of them has limited efficacies and serious adverse effects. Pluchea indica (L.) Less. tea (PIT) is widely consumed as a health-promoting drink in Southeast Asia. This study aimed to investigate whether P. indica tea has antidyslipidemic and antihyperglycemic effects and toxicity in humans. Design: A randomized clinical trial. Setting/Location: Nakhonratchasima, Thailand. Participants: Forty-five participants with prediabetes. Interventions: Participants were randomized to receive placebo tea, 1.5 g of PIT, and 1.5 g Camellia sinensis tea (green tea, CST) once daily for 12 weeks. Outcome Measurements: The oral glucose tolerance test (OGTT), total cholesterol, triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), blood urea nitrogen (BUN), creatinine, alanine transaminase (ALT), alkaline phosphatase (ALP), and complete blood count (CBC) before and after treatment were investigated. Results: The results showed that PIT significantly ameliorated hyperglycemia and significantly lower serum TG (109.22 +/- 5.21 mg/dL) and LDL-C (122.20 +/- 3.67 mg/dL) than placebo (145.56 +/- 8.18 and 142.07 +/- 8.58 mg/dL, respectively) (p < 0.05). Moreover, PIT exhibited serum TG (109.22 +/- 5.21 mg/dL) significantly lower than CST (124.38 +/- 4.70 mg/dL) (p < 0.05). In addition, the serum HDL-C of PIT (57.56 +/- 3.05 mg/dL) was significantly higher than the placebo (46.44 +/- 2.47 mg/dL) (p < 0.05). Furthermore, the toxicity testing showed that no significant difference in BUN, creatinine, ALT, ALP, and CBC of PIT-treated group compared with the placebo (p > 0.05). Conclusions: These results suggest that PIT may ameliorate hyperglycemia and dyslipidemia in prediabetes people. It may not be toxic to the kidney, liver, and blood. So, PIT has the potential to develop to be a health-promoting tea or herbal medicine for hyperglycemia and dyslipidemia prevention.
引用
收藏
页码:669 / 677
页数:9
相关论文
共 50 条
  • [41] Pistachio Nut Effects on the Blood Lipid Profile in Patients With Type II Diabetes Mellitus: A Single-Blind Randomized Crossover Controlled Clinical Trial
    Khorramirad, Ashraf
    Heidari, Saeide
    Parham, Mahmoud
    Jang, Shahram Arsang
    Hozoori, Mohammad
    IRANIAN HEART JOURNAL, 2021, 22 (03): : 23 - 32
  • [42] Aqueous extract of Peristrophe bivalvis (L.) Merr. leaf reversed the detrimental effects of nitric oxide synthase inhibitor on blood lipid profile and glucose level
    Aluko, Esther Oluwasola
    David, Ubong Edem
    Ojetola, Abodunrin Adebayo
    Fasanmade, Adesoji Adedipe
    PLOS ONE, 2024, 19 (09):
  • [43] Berberine phospholipid exerts a positive effect on the glycemic profile of overweight subjects with impaired fasting blood glucose (IFG): a randomized double-blind placebo-controlled clinical trial
    Rondanelli, M.
    Gasparri, C.
    Petrangolini, G.
    Allegrini, P.
    Avenoso, D.
    Fazia, T.
    Bernardinelli, L.
    Peroni, G.
    Patelli, Z.
    Mansueto, F.
    Tartara, A.
    Cavioni, A.
    Riva, A.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (14) : 6718 - 6727
  • [44] Effect of Juglans regia L. Ridge on Blood Lipids in Type 2 Diabetic Patients with Dyslipidemia: A Double-blind Placebo-Controlled Randomized Clinical Trial
    Mirshekari, Mehrzad
    Zargaran, Arman
    Shirzad, Nooshin
    Hemmatabadi, Mahboobeh
    Khanavi, Mahnaz
    Ebrahimpur, Mahbube
    Afra, Fatemeh
    Namazi, Soha
    PHARMACEUTICAL SCIENCES, 2023, 29 (02) : 182 - 189
  • [45] Effect of L-Carnitine Supplementation on Inflammatory Markers and Serum Glucose in Hemodialysis Children: A Randomized, Placebo-Controlled Clinical Trial
    Hamedi-kalajahi, Fatemeh
    Imani, Hossein
    Mojtahedi, SayedYousef
    Shabbidar, Sakineh
    JOURNAL OF RENAL NUTRITION, 2022, 32 (02) : 144 - 151
  • [46] The Effects of Satureja hortensis L. Dried Leaves on Serum Sugar, Lipid Profiles, hs-CRP, and Blood Pressure in Metabolic Syndrome Patients: A Double-Blind Randomized Clinical Trial
    Nikaein, Farzad
    Babajafari, Siavash
    Mazloomi, Seyed Mohammad
    Zibaeenezhad, Mohammadjavad
    Zargaran, Arman
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2017, 19 (01)
  • [47] The effect of Allium hirtifolium bulb on serum lipid profile in adult patients with hyperlipidemia: A randomized double-blind placebo-controlled clinical trial
    Heshmat-Ghahdarijani, Kiyan
    Soltani, Rasool
    Ghanadian, Mustafa
    Soleymani, Hassan
    COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE, 2022, 49
  • [48] Effect of Dietary Purified Xanthohumol from Hop (Humulus lupulus L.) Pomace on Adipose Tissue Mass, Fasting Blood Glucose Level, and Lipid Metabolism in KK-Ay Mice
    Takahashi, Koki
    Osada, Kyoichi
    JOURNAL OF OLEO SCIENCE, 2017, 66 (05) : 531 - 541
  • [49] Effect of caper fruit (Capparis spinosa L.) consumption on liver enzymes, lipid profile, fasting plasma glucose, and weight loss. A systematic review and a preliminary meta-analysis of randomized controlled trials
    Perna, Simone
    Rafique, Ayesha
    Rondanelli, Mariangela
    Allehdan, Sabika
    Riso, Patrizia
    Marino, Mirko
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 168
  • [50] Astaxanthin supplementation impact on insulin resistance, lipid profile, blood pressure, and oxidative stress in polycystic ovary syndrome patients: A triple-blind randomized clinical trial
    Jabarpour, Masoome
    Aleyasin, Ashraf
    Nashtaei, Maryam Shabani
    Amidi, Fardin
    PHYTOTHERAPY RESEARCH, 2024, 38 (01) : 321 - 330